Globe Life 10-Q: Q3 Net Income $361.1M, Diluted EPS $4.62, $120.5M Reserve Gain
GL sits 25% above its 52-week low of $129.21.
Summary
Globe Life's Q3 10-Q shows net income of $361.1 million, or $4.62 per diluted share, helped by a $120.5 million pretax reserve gain, with health margins squeezed by Evry Health losses.
Key Events · Earnings and Guidance · GL
-
Q3 Net Income $361.1M, EPS $4.62
Third-quarter revenue was $1.60 billion and net income $361.1 million, or $4.62 per diluted share, versus $4.73 a year earlier. For the nine months, net income was $919.4 million, or $11.64 per diluted share.
-
$120.5M Reserve Remeasurement Gain
The annual assumption review produced a $120.5 million pretax net remeasurement gain ($96.4 million life, $24.1 million health), down from $134.3 million in the year-ago quarter, so the year-over-year profit decline partly reflects a smaller actuarial tailwind.
-
Health Margin Squeezed by Evry
Health underwriting margin rose to $309.4 million from $291.2 million, but United American's margin fell to 2% from 6% as Evry Health claims drove a $26 million underwriting loss; management warns of continued volatility as Evry scales.
-
Buybacks and 22% Dividend Increase
Globe Life repurchased 3.6 million shares for $564 million at an average $155.30 in the first nine months, with $2.4 billion remaining under the authorization, and raised the quarterly dividend 22% to $0.33 per share.
Analysis · GL · Finance
The headline numbers were already out on October 21, but this 10-Q is where the detail lives. Profit for the quarter leaned on a $120.5 million pretax reserve remeasurement gain from the annual assumption review, down from $134.3 million a year ago, so the underlying underwriting trend is softer than the headline suggests. Health is the pressure point: United American's underwriting margin fell to 2% from 6% as Evry Health's group medical business ran a $26 million underwriting loss, and management flags continued volatility there. Against that, life premium grew 3% and health premium 15%, book value per share rose 23% to $85.35, and the company bought back 3.6 million shares for $564 million while raising the dividend 22% to $0.33.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GL was trading at $161.72 on NYSE in the Finance sector, with a market capitalization of approximately $12.4B. The 52-week trading range was $129.21 to $191.55. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.